Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Tangney

Showing results (31-40 of 88) with videos related to

Pageof 9
Sort By:
Postgraduate Medicine|May 14, 2010
Gene therapy for prostate cancerMark Tangney, Sarfraz Ahmad, Sara A Collins, et al.
Expert Reviews in Molecular Medicine|April 3, 2023
<i>Fusobacterium nucleatum</i>: a novel immune modulator in breast cancer?Alexa Little, Mark Tangney, Michael M Tunney, et al.
Current Gene Therapy|January 24, 2012
PET imaging for gene & cell therapySara A Collins, Kei Hiraoka, Akihito Inagaki, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 28, 2012
Polymer coatings for delivery of nucleic acid therapeuticsRichard Laga, Robert Carlisle, Mark Tangney, et al.
Genetic Vaccines and Therapy|February 26, 2010
Optimised electroporation mediated DNA vaccination for treatment of prostate cancerSarfraz Ahmad, Garrett Casey, Paul Sweeney, et al.
Frontiers in Bioengineering and Biotechnology|April 22, 2024
Synthetic protein protease sensor platformCiaran Devoy, Yensi Flores Bueso, Stephen Buckley, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 2, 2009
Prostate stem cell antigen DNA vaccination breaks tolerance to self-antigen and inhibits prostate cancer growthSarfraz Ahmad, Garrett Casey, Paul Sweeney, et al.
Computational and Structural Biotechnology Journal|June 3, 2026
Protein Design Enters the Artificial Intelligence Era: Foundations, Tools, and Emerging ParadigmsYanlin Mi, Arpit Shukla, Mark Tangney, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 15, 2015
Activation of multiple chemotherapeutic prodrugs by the natural enzymolome of tumour-localised probiotic bacteriaPanos Lehouritis, Michael Stanton, Florence O McCarthy, et al.
Bioengineered Bugs|April 7, 2011
Bacteria as vectors for gene therapy of cancerChwanrow K Baban, Michelle Cronin, Deirdre O'Hanlon, et al.
Pageof 9

Showing results (31-40 of 88) with videos related to

Sort By:
Pageof 9
Postgraduate Medicine|May 14, 2010
Gene therapy for prostate cancerMark Tangney, Sarfraz Ahmad, Sara A Collins, et al.
Expert Reviews in Molecular Medicine|April 3, 2023
<i>Fusobacterium nucleatum</i>: a novel immune modulator in breast cancer?Alexa Little, Mark Tangney, Michael M Tunney, et al.
Current Gene Therapy|January 24, 2012
PET imaging for gene & cell therapySara A Collins, Kei Hiraoka, Akihito Inagaki, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 28, 2012
Polymer coatings for delivery of nucleic acid therapeuticsRichard Laga, Robert Carlisle, Mark Tangney, et al.
Genetic Vaccines and Therapy|February 26, 2010
Optimised electroporation mediated DNA vaccination for treatment of prostate cancerSarfraz Ahmad, Garrett Casey, Paul Sweeney, et al.
Frontiers in Bioengineering and Biotechnology|April 22, 2024
Synthetic protein protease sensor platformCiaran Devoy, Yensi Flores Bueso, Stephen Buckley, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 2, 2009
Prostate stem cell antigen DNA vaccination breaks tolerance to self-antigen and inhibits prostate cancer growthSarfraz Ahmad, Garrett Casey, Paul Sweeney, et al.
Computational and Structural Biotechnology Journal|June 3, 2026
Protein Design Enters the Artificial Intelligence Era: Foundations, Tools, and Emerging ParadigmsYanlin Mi, Arpit Shukla, Mark Tangney, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 15, 2015
Activation of multiple chemotherapeutic prodrugs by the natural enzymolome of tumour-localised probiotic bacteriaPanos Lehouritis, Michael Stanton, Florence O McCarthy, et al.
Bioengineered Bugs|April 7, 2011
Bacteria as vectors for gene therapy of cancerChwanrow K Baban, Michelle Cronin, Deirdre O'Hanlon, et al.
Pageof 9